Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J. P. Van Der Post
Observed names:
J. P. van der Post,
J.P. van der Post
Institution:
Centre for Human Drug Research
Observed institution:
Centre for Human Drug Research
OpenAlex ID:
A5111956979
Biomarkers for the effects of benzodiazepines in healthy volunteers
2003
·
S. J. De Visser
, J. P. Van Der Post
, et al.
·
British Journal of Clinical Pharmacology
·
141
PDF
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA A α 2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers
2007
·
S.L. de Haas
, S.J. de Visser
, et al.
·
Journal of Psychopharmacology
·
109
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA A α 2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers
2007
·
S.L. de Haas
, S.J. de Visser
, et al.
·
Journal of Psychopharmacology
·
98
The central nervous system effects, pharmacokinetics and safety of the NAALADase‐inhibitor GPI 5693
2005
·
J. P. Van Der Post
, S. J. De Visser
, et al.
·
British Journal of Clinical Pharmacology
·
68
PDF
Pharmacokinetic/pharmacodynamic Assessment of Tolerance to Central Nervous System Effects of a 3 mg Sustained Release Tablet of Rilmenidine in Hypertensive Patients
2004
·
J. P. van der Post
, S. J. de Visser
, et al.
·
Journal of Psychopharmacology
·
18
Show more works
View as search
Works count:
5
Citation count:
434
H-index:
5
I10-index:
5
Year
Topic
Type